Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Conagra Brands Reports Fourth Quarter Fiscal 2026 Financial Results

Conagra Brands, Inc., the Chicago-based packaged food company behind well-known consumer brands, disclosed its fourth quarter fiscal 2026 financial results on July 15, 2026, through a press release issued the same day. The announcement represents the company's final quarterly earnings update for fiscal year …

Vinay Lochav | 15 July 2026

Entegris Declares $0.10 Quarterly Cash Dividend Payable August 19, 2026

Entegris, Inc., the Billerica, Massachusetts-based semiconductor materials and solutions company, has announced that its board of directors declared a quarterly cash dividend of $0.10 per share, according to a disclosure filed on July 15, 2026. The dividend is scheduled to be paid on August …

Nitish Kishor | 15 July 2026

FDA Accepts Axsome Therapeutics' New Drug Application for AXS-12 (Reboxetine) to Treat Cataplexy in Narcolepsy

Axsome Therapeutics, Inc. has announced that the U.S. Food and Drug Administration has accepted for filing the company's New Drug Application for AXS-12 (reboxetine), a candidate being developed for the treatment of cataplexy in patients with narcolepsy. The announcement, made on July 15, 2026, …

Vinay Lochav | 15 July 2026

PNC Financial Services Group Reports Second Quarter 2026 Earnings and Business Results

The PNC Financial Services Group, Inc. announced its earnings and business results for the second quarter of 2026 on July 15, 2026, disclosing the update alongside supplementary financial information made available on the company's website. The announcement, signed by Senior Vice President and Controller …

Manish Choudhary | 15 July 2026

BlackRock Reports Second Quarter 2026 Financial Results, Schedules Investor Conference Call and Webcast

BlackRock, Inc. disclosed its results of operations for the three and six months ended June 30, 2026, on July 15, 2026, filing a current report with U.S. securities regulators. The company simultaneously announced it would hold an investor conference call and webcast on the …

Manish Choudhary | 15 July 2026

First Horizon Corporation Releases Second Quarter 2026 Earnings Results and Investor Presentation

First Horizon Corporation, the Memphis, Tennessee-based regional bank holding company trading on the New York Stock Exchange under the ticker FHN, released its Second Quarter 2026 Earnings on July 15, 2026, alongside a companion Investor Slide Presentation covering the quarter ended June 30, 2026. …

Anjali Anand | 15 July 2026

M&T Bank Corporation Reports Second Quarter 2026 Results and Releases Investor Presentation on July 15

M&T Bank Corporation, the Buffalo, New York-based regional banking institution whose common stock trades on the New York Stock Exchange under the ticker MTB, announced its results of operations for the quarter ended June 30, 2026, on July 15, 2026. Alongside the earnings announcement, …

Anjali Anand | 15 July 2026

Elevance Health Reports Second Quarter 2026 Financial Results in July 15 Disclosure

Elevance Health, Inc., the Indianapolis-based managed care and health benefits company, issued a press release on July 15, 2026, reporting its financial results for the second quarter ended June 30, 2026. The announcement was made public through a current report filed with regulators and …

Shwetambri Chauhan | 15 July 2026

News Corporation Discloses Ongoing Share Buyback Activity Under $1 Billion Repurchase Program in ASX Filing Update

News Corporation, the global media and information services company listed on the Nasdaq Global Select Market, has filed a current report disclosing share repurchase activity under its previously authorized $1 billion stock buyback program, with corresponding notices submitted to the Australian Securities Exchange. The …

Vinay Lochav | 15 July 2026

Celcuity Wins FDA Approval for REVTORPYK (Gedatolisib) in HR+/HER2- Metastatic Breast Cancer Without PIK3CA Mutation

Celcuity Inc., the Minneapolis-based clinical-stage biopharmaceutical company trading on NASDAQ under the ticker CELC, announced on July 14, 2026 that the U.S. Food and Drug Administration has approved REVTORPYK™ (gedatolisib) for a specific and previously underserved segment of the hormone receptor positive, HER2-negative metastatic …

Manish Choudhary | 15 July 2026
Support

Hi! How can we help you today?

Loading…